首页> 外文期刊>The American journal of hospice and palliative care >Establishing the safety and efficacy of an opioid titration protocol.
【24h】

Establishing the safety and efficacy of an opioid titration protocol.

机译:建立阿片类药物滴定方案的安全性和有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

The primary goal of this single-group study was to determine the safety of a standard opioid titration order sheet to manage pain in ambulatory cancer patients. Secondary goals were to examine opioid toxicity and efficacy of this pain protocol. Twenty-seven patients who required fixed-dose opioids and who had uncontrolled pain were enrolled. All patients had their initial opioid dose titrated by the study physician using the opioid titration order sheet. Data were obtained by the study nurse during a weekly telephone interview and used to determine if pain was controlled. After initial titration, a trained study nurse titrated opioid doses based upon the standing order sheet. At each contact, patients were assessed for adverse effects, pain intensity, and analgesics used. Patients who completed the four-week trial (n = 17) did not differ from patients who did not complete the trial. No adverse effects were observed in 39 opioid titrations completed by the study nurse. Opioid toxicities, worst pain, usual pain, and pain-related distress declined from baseline to week four Patients who were adherent to their prescribed medications reported significantly lower pain intensity and distress (ps < or = . 06). The opioid titration order sheet, used by a trained nurse, is safe to use in ambulatory cancer patients who have moderate to severe pain. Common opioid toxicities were reduced. The protocol also demonstrated initial efficacy in improving worst and usual pain and pain-related distress. Further research to establish efficacy of the protocol is recommended.
机译:这项单组研究的主要目的是确定标准阿片类药物滴定顺序表管理可移动性癌症患者疼痛的安全性。次要目标是检查这种镇痛方案的阿片类药物毒性和疗效。入选需要固定剂量阿片类药物且疼痛不受控制的患者27例。研究医师使用阿片类药物滴定顺序表对所有患者的初始阿片类药物剂量进行滴定。研究护士在每周的电话访问中获得了数据,并用于确定疼痛是否得到控制。初始滴定后,训练有素的研究护士根据常规订购单对阿片类药物剂量进行滴定。在每次接触时,评估患者的不良反应,疼痛强度和使用的止痛药。完成四周试验的患者(n = 17)与未完成试验的患者没有差异。在由研究护士完成的39次阿片类药物滴定中未观察到不良反应。阿片类药物的毒性,最严重的疼痛,常见的疼痛以及与疼痛相关的困扰从基线降低到第四周,坚持使用处方药的患者的疼痛强度和困扰明显降低(ps <或= .06)。由受过训练的护士使用的阿片类药物滴定单可安全用于中度至重度疼痛的门诊癌症患者。常见的阿片类药物毒性降低。该协议还证明了在减轻最严重和常见疼痛以及与疼痛相关的困扰方面的初步功效。建议进行进一步研究以建立方案的效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号